DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown, President and CEO, Dr. Norman Sussman, Chief Medical Officer, and Dr....
Stay updated with breaking news from Ed Arce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown, President and CEO, Dr. Norman Sussman, Chief Medical Officer, and Dr....
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown, President and CEO, Dr. Norman Sussman, Chief Medical Officer, and Dr....
AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti -...
H.C. Wainwright has trimmed the price target on the clinical-stage biopharma company CymaBay Therapeutics (CBAY) on Monday, citing a delay in the enrollment for the second global Phase...
CBAY earnings call for the period ending March 31, 2022.